Newron Pharmaceuticals SpA (NWRN) - Total Liabilities

Latest total liabilities as of June 2025: CHF59.81 Million CHF

Based on the latest financial reports, Newron Pharmaceuticals SpA (NWRN) has total liabilities worth CHF59.81 Million CHF as of June 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Newron Pharmaceuticals SpA - Total Liabilities Trend (2005–2024)

This chart illustrates how Newron Pharmaceuticals SpA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Newron Pharmaceuticals SpA Competitors by Total Liabilities

The table below lists competitors of Newron Pharmaceuticals SpA ranked by their total liabilities.

Liability Composition Analysis (2005–2024)

This chart breaks down Newron Pharmaceuticals SpA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Newron Pharmaceuticals SpA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Newron Pharmaceuticals SpA (2005–2024)

The table below shows the annual total liabilities of Newron Pharmaceuticals SpA from 2005 to 2024.